Sugar intake has long been connected to the development of serious diseases like diabetes, cancer and even early death. This fact has prompted the government to rethink its approach to encouraging citizens from giving up their sugar intake.
Scientists have reported that in humans, obesity can break down the protective blood barrier resulting in problems with learning and memory. Also, scientists know that chronic activation of the receptor Adora2a on the endothelial cells that line this essential barrier in the human brain can let factors from the blood enter the brain and disturb the performance of human neurons.
The latest research study has unveiled that Type 2 diabetes patients with obstructive sleep apnea or OSA could be the victims of blindness within an average period of four years.
A recent study has unveiled that the drug canagliflozin plays important role in treating the type 2 diabetes and simultaneously reduces the risk of the kidney problem and heart disease.
Researchers from the University of Copenhagen, University of Colorado, Tufts University and two institutions presented data that showed the determining factor of weight loss in fasting plasma glucose.